These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 35378546)
1. Colonoscopy Findings in FIT+ and mt-sDNA+ Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data. Anderson JC; Robinson CM; Hisey W; Limburg PJ; Butterly LF Cancer Prev Res (Phila); 2022 Jul; 15(7):455-464. PubMed ID: 35378546 [TBL] [Abstract][Full Text] [Related]
2. Serrated Polyp Yield at Colonoscopy in Patients with Positive FIT, Positive mt-sDNA, and Colonoscopy Only: Data from the New Hampshire Colonoscopy Registry. Anderson JC; Hisey WM; Robinson CM; Limburg PJ; Kneedler BL; Butterly LF Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):226-232. PubMed ID: 36409472 [TBL] [Abstract][Full Text] [Related]
3. What do 'false-positive' stool tests really mean? Data from the New Hampshire colonoscopy registry. Butterly LF; Hisey WM; Robinson CM; Limburg PJ; Kneedler BL; Anderson JC Prev Med Rep; 2023 Oct; 35():102309. PubMed ID: 37449002 [TBL] [Abstract][Full Text] [Related]
4. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091 [TBL] [Abstract][Full Text] [Related]
5. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry. Anderson JC; Robinson CM; Hisey WM; Edwards DK; Kneedler BL; Berger BM; Butterly LF J Clin Gastroenterol; 2022 May-Jun 01; 56(5):419-425. PubMed ID: 33973962 [TBL] [Abstract][Full Text] [Related]
6. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes. Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023 [TBL] [Abstract][Full Text] [Related]
7. Association of Endoscopist Colonoscopy Quality Measures With Follow-Up Colonoscopy Outcomes After Positive Stool Tests (Multitarget Stool DNA or Fecal Immunochemical Test): Retrospective Cross-Sectional Analysis of Data From the New Hampshire Colonoscopy Registry. Butterly LF; Hisey WM; Robinson CM; Kneedler BL; Anderson JC Am J Gastroenterol; 2024 Nov; 119(11):2215-2223. PubMed ID: 38629701 [TBL] [Abstract][Full Text] [Related]
8. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests. Pickhardt PJ; Correale L; Hassan C AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913 [No Abstract] [Full Text] [Related]
9. Performance of multitarget stool DNA testing in African American patients. Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399 [TBL] [Abstract][Full Text] [Related]
10. Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People. Redwood DG; Asay ED; Blake ID; Sacco PE; Christensen CM; Sacco FD; Tiesinga JJ; Devens ME; Alberts SR; Mahoney DW; Yab TC; Foote PH; Smyrk TC; Provost EM; Ahlquist DA Mayo Clin Proc; 2016 Jan; 91(1):61-70. PubMed ID: 26520415 [TBL] [Abstract][Full Text] [Related]
11. Colonoscopy after a Positive Stool-based Test for Colon Cancer Screening: Moving Toward a Better Understanding of What to Expect. Krigel A; Wan DW Cancer Prev Res (Phila); 2022 Jul; 15(7):417-418. PubMed ID: 35788831 [TBL] [Abstract][Full Text] [Related]
12. Influence of Colorectal Cancer Risk Factors on Predictive Value of a Positive Multitarget Stool DNA Test. Narayani KR; Narayani RI J Clin Gastroenterol; 2024 May-Jun 01; 58(5):471-474. PubMed ID: 37389965 [TBL] [Abstract][Full Text] [Related]
14. Risk of Metachronous High-Risk Adenomas and Large Serrated Polyps in Individuals With Serrated Polyps on Index Colonoscopy: Data From the New Hampshire Colonoscopy Registry. Anderson JC; Butterly LF; Robinson CM; Weiss JE; Amos C; Srivastava A Gastroenterology; 2018 Jan; 154(1):117-127.e2. PubMed ID: 28927878 [TBL] [Abstract][Full Text] [Related]
15. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening. Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667 [TBL] [Abstract][Full Text] [Related]
16. Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening. Johnson DH; Kisiel JB; Burger KN; Mahoney DW; Devens ME; Ahlquist DA; Sweetser S Gastrointest Endosc; 2017 Mar; 85(3):657-665.e1. PubMed ID: 27884518 [TBL] [Abstract][Full Text] [Related]
17. Detection of High-Risk Sessile Serrated Lesions: Multitarget Stool DNA Versus CT Colonography. Deiss-Yehiely N; Graffy PM; Weigman B; Hassan C; Matkowskyj KA; Pickhardt PJ; Weiss JM AJR Am J Roentgenol; 2022 Apr; 218(4):670-676. PubMed ID: 34755523 [No Abstract] [Full Text] [Related]
19. Colonoscopy Outcomes in Average-Risk Screening Equivalent Young Adults: Data From the New Hampshire Colonoscopy Registry. Butterly LF; Siegel RL; Fedewa S; Robinson CM; Jemal A; Anderson JC Am J Gastroenterol; 2021 Jan; 116(1):171-179. PubMed ID: 32833734 [TBL] [Abstract][Full Text] [Related]
20. The Utility of Multitarget Stool DNA Testing for Colorectal Cancer Screening After a Normal Colonoscopy. Rao AK; Kalra S; Van Leer-Greenberg B; Rockey DC J Gastrointest Cancer; 2024 Oct; 56(1):2. PubMed ID: 39414672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]